No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.
第一作者:
Junki,Ishii
第一单位:
Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
作者:
主题词
人类(Humans);卡巴配能类(Carbapenems);危重病(Critical Illness);男(雄)性(Male);前瞻性研究(Prospective Studies);女(雌)性(Female);抗药性, 多种, 细菌(Drug Resistance, Multiple, Bacterial);老年人(Aged);抗菌药(Anti-Bacterial Agents);中年人(Middle Aged);重症监护病房(Intensive Care Units);细菌感染(Bacterial Infections);日本(Japan);老年人, 80以上(Aged, 80 and over);细菌(Bacteria)
DOI
10.1128/spectrum.00342-24
PMID
38864641
发布时间
2024-10-11
- 浏览0

Microbiology spectrum
2024年12卷7期
e0034224页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文